- Home
- RLMD vs CMCM Comparison
RLMD vs CMCM Comparison
Compare RLMD & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- CMCM
- Stock Information
- Founded
- RLMD 2004
- CMCM 2009
- Country
- RLMD United States
- CMCM China
- Employees
- RLMD N/A
- CMCM N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- CMCM Computer Software: Prepackaged Software
- Sector
- RLMD Health Care
- CMCM Technology
- Exchange
- RLMD Nasdaq
- CMCM Nasdaq
- Market Cap
- RLMD 110.6M
- CMCM 132.7M
- IPO Year
- RLMD N/A
- CMCM 2014
- Fundamental
- Price
- RLMD $2.75
- CMCM $4.62
- Analyst Decision
- RLMD Hold
- CMCM
- Analyst Count
- RLMD 2
- CMCM 0
- Target Price
- RLMD $7.50
- CMCM N/A
- AVG Volume (30 Days)
- RLMD 126.6K
- CMCM 21.7K
- Earning Date
- RLMD 11-07-2024
- CMCM 11-29-2024
- Dividend Yield
- RLMD N/A
- CMCM N/A
- EPS Growth
- RLMD N/A
- CMCM N/A
- EPS
- RLMD N/A
- CMCM N/A
- Revenue
- RLMD N/A
- CMCM $97,678,928.00
- Revenue This Year
- RLMD N/A
- CMCM N/A
- Revenue Next Year
- RLMD N/A
- CMCM N/A
- P/E Ratio
- RLMD N/A
- CMCM N/A
- Revenue Growth
- RLMD N/A
- CMCM N/A
- 52 Week Low
- RLMD $1.88
- CMCM $1.87
- 52 Week High
- RLMD $7.22
- CMCM $6.78
- Technical
- Relative Strength Index (RSI)
- RLMD 23.58
- CMCM 55.34
- Support Level
- RLMD $2.96
- CMCM $4.00
- Resistance Level
- RLMD $3.43
- CMCM $4.69
- Average True Range (ATR)
- RLMD 0.21
- CMCM 0.26
- MACD
- RLMD -0.07
- CMCM 0.00
- Stochastic Oscillator
- RLMD 1.60
- CMCM 66.59
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About CMCM Cheetah Mobile Inc. each representing fifty (50)
Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.